PUBLISHER: Allied Market Research | PRODUCT CODE: 1365682
PUBLISHER: Allied Market Research | PRODUCT CODE: 1365682
According to a new report published by Allied Market Research, titled, "cementless total knee arthroplasty Market," The cementless total knee arthroplasty market was valued at $1.9 billion in 2022, and is estimated to reach $3 billion by 2032, growing at a CAGR of 4.6% from 2023 to 2032.
Major factors that drive the growth of the global cementless total knee arthroplasty market include increase in prevalence of rheumatoid arthritis and sports-related injuries, technological advancement in implant designs, materials, and surgical techniques that has significantly improved the outcomes of cementless knee arthroplasty. For instance, according to the report published by Global RA Network, in 2021, it has been reported that more than 350 million people have arthritis globally in which up to 3% of the global population has psoriatic arthritis and 14 million people have rheumatoid arthritis.,
Furthermore, the surge in the number of R&D activities for the development of technologically advanced medical devices used in knee arthroplasty and rapidly growing geriatric population are the factors that propel the growth of the market. In addition, the advantage of cementless knee arthroplasty over cemented implants such as better fixation, reduced risk of loosening, decreased complications associated with cement, and potential ease of revision surgeries leading to a shift toward cementless knee arthroplasty that increases the adoption of the cementless total knee arthroplasty platforms, thus propelling the market growth.
However, the high cost associated with cementless knee arthroplasty implants and easy availability of alternatives such as cemented knee arthroplasty are the major barriers to the growth of the market. On the contrary, growing patients' preference for cementless implants and favorable reimbursement policies and insurance coverage for cementless knee arthroplasty procedures are expected to offer remunerative opportunities for the expansion of the global cementless total knee arthroplasty market in the future.
The global cementless total knee arthroplasty market is segmented into product, material, end user, and region. On the basis of the product, the market is segmented into mobile bearings and fixed bearings. On the basis of the material, the market is segmented into ceramics, alloy, and others. Depending on end user, it is bifurcated into hospitals and others. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
The major players profiled in the report are Zimmer Biomet Holdings Inc, Smith & Nephew PLC, Stryker Corporation, Johnson & Johnson, B. Braun Melsungen AG, Microport Scientific Corporation, Olympus Corporation (Group FH Ortho), Waldemar Link GmbH & Co. KG, United Orthopedic Corporation, and X. NOV. The major players in the market have adopted product launch and innovation as key developmental strategies to improve the product portfolio of the cementless total knee arthroplasty market.
Additional benefits you will get with this purchase are:
Possible Customization with this report (with additional cost and timeline talk to the sales executive to know more)